Hepatitis b drug trial halted after early safety check

NCT ID NCT05763576

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new medicine called RO7565020 in healthy volunteers and people with chronic hepatitis B. The goal was to see if the drug is safe and how the body processes it. The trial was stopped early, so results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chang Gung Medical Foundation Linkou Branch

    Taoyuan City, 333, Taiwan

  • Faculty of Medicine Siriraj Hospital

    Bangkok, 10700, Thailand

  • Hallym University Chuncheon Sacred Heart Hospital

    Chuncheon, 24253, South Korea

  • Hospital Alvaro Cunqueiro

    Vigo, Pontevedra, 36312, Spain

  • Maharaj Nakorn Chiang Mai Hospital

    Chiang Mai, 50200, Thailand

  • New Zealand Clinical Research - Auckland

    Auckland, 1010, New Zealand

  • Prince of Wales Hospital

    Shatin, New Territories, Hong Kong

  • Queen Mary Hospital

    Hong Kong, Hong Kong

  • Quest Clinical Research

    San Francisco, California, 94115, United States